Application of antimicrobial photodynamic therapy to treat subgingival multidrug-resistant bacterial infections in ICU patients (2022)

Peer-Reviewed Study · Song C; Dai F; Ning Y; Deng T; Yang Y; Zhu H; Song L · November 15, 2022

Song C et al., 2022-11-15: Intraoral split-mouth randomised trial in 83 ICU patients with subgingival multidrug-resistant bacteria: methylene blue aPDT reduced MDR counts immediately, better than chlorhexidine or saline, but the difference disappeared by 6 hours.

The MDR bacterial count decreased immediately after aPDT and was significantly different from that in the chlorhexidine gargle rinse group and the normal saline rinse group (P<0.05). There was no significant difference among the three groups at 6, 12, and 24 hours after treatment (P>0.05).

Abstract

Song C et al., 2022-11-15: Intraoral split-mouth randomised trial in 83 ICU patients with subgingival multidrug-resistant bacteria: methylene blue aPDT reduced MDR counts immediately, better than chlorhexidine or saline, but the difference disappeared by 6 hours. Study type: intraoral partitioned-control randomised trial (teeth from different quadrants of the same patient assigned to aPDT, chlorhexidine or saline). N=83 ICU patients, Nanchang University Second Affiliated Hospital, China, July 2019-June 2021. Comparator: 0.9% saline and chlorhexidine gargle. Outcome: MDR colony counts in gingival crevicular fluid at 0, 6, 12, 24 h. Conflicts: none declared. Bearing: real but short-lived effect , an honest limitation for any 'treats resistant infection' claim. Study type: randomized trial.